Submitting OIG:
Report Description:
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, prior OIG reviews found that States did not always invoice and collect all rebates due for drugs administered by physicians.
Date Issued:
Tuesday, June 18, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-05-18-00030
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$4,065,188
Number of Recommendations:
5
View Document:
Attachment | Size |
---|---|
51800030.pdf | 533.74 KB |
Additional Details Link: